Cardio-oncology Outcomes in Ultrasound-assisted Versus Standard Catheter-directed Thrombolysis for Acute Pulmonary Embolus

Acute pulmonary embolism (PE) is the third leading cause of cardiovascular death, claiming the lives of over 100,000 people annually in the United States alone.1 Systemic thrombolysis (ST) remains the traditional treatment for high-risk PE, although its effectiveness in reaching the clot can be limited, and its safety can be significantly challenged by major bleeding (including up to 1.5% intracranial bleeding). Catheter-directed therapy (CDT) is a newer and more targeted technique in which thrombolytics are directly applied onto the thrombus of intermediate and high-risk PE using standard catheter-directed thrombolysis (SCDT) and ultrasound-assisted thrombolysis (USAT), with the latter consisting of high-frequency acoustics added to SCDT to improve thrombolytic penetration for greater dissociation of fibrin strands.

Authors

Institutions

Publication Details

Journal
Journal of the Society for Cardiovascular Angiography & Interventions
Published
2025-05-02
DOI
https://doi.org/10.1016/j.jscai.2025.103659
Primary Topic
Venous Thromboembolism Diagnosis and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cardio-oncology Outcomes in Ultrasound-assisted Versus Standard Catheter-directed Thrombolysis for Acute Pulmonary Embolus

Kevin A. Honan, K. Mackay, Salman Arain, Teodora Donisan et al.
Journal of the Society for Cardiovascular Angiography & Interventions
Venous Thromboembolism Diagnosis and Management
article

Cardio-oncology Outcomes in Ultrasound-assisted Versus Standard Catheter-directed Thrombolysis for Acute Pulmonary Embolus

Kevin A. Honan, K. Mackay, Salman Arain, Teodora Donisan, Hyeon‐Ju Ali, Konstantinos Charitakis, Arashk Motiei, Mehmet Çilingiroğlu, Jaime Caballero, Dominique Monlezun, Dinu Valentin Balanescu, Konstantinos Marmagkiolis, Brenden Ingraham, Konstantinos Dean Boudoulas, Abdelrahman Ali, Cezar Iliescu
article en

Abstract

Acute pulmonary embolism (PE) is the third leading cause of cardiovascular death, claiming the lives of over 100,000 people annually in the United States alone.1 Systemic thrombolysis (ST) remains the traditional treatment for high-risk PE, although its effectiveness in reaching the clot can be limited, and its safety can be significantly challenged by major bleeding (including up to 1.5% intracranial bleeding). Catheter-directed therapy (CDT) is a newer and more targeted technique in which thrombolytics are directly applied onto the thrombus of intermediate and high-risk PE using standard catheter-directed thrombolysis (SCDT) and ultrasound-assisted thrombolysis (USAT), with the latter consisting of high-frequency acoustics added to SCDT to improve thrombolytic penetration for greater dissociation of fibrin strands.

Journal of the Society for Cardiovascular Angiography & InterventionsVol. 4(6)
Mayo Clinic (US), Ochsner Health System (US), The University of Texas MD Anderson Cancer Center (US), University of South Florida (US), Tampa General Hospital (US), The University of Texas Health Science Center (US), The Ohio State University (US)
Good health and well-being
Openalex Percentile: Top 80%
Venous Thromboembolism Diagnosis and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.